US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Septerna, Inc.

6.69

-0.2600-3.74%

Post-market: 6.690.00000.00%16:05 EDT

Volume:164.76K

Turnover:1.11M

Market Cap:297.32M

PE:-0.92

High:7.16

Open:6.96

Low:6.65

Close:6.95

Loading ...

Overview Company News Filings

Septerna Shares Fall 7% After Wider 3Q Loss

Septerna's Q3 Loss Widens, Revenue Rises

MT Newswires Live

BRIEF-Septerna Reports Third Quarter 2024 Financial Results And Recent Business Highlights

Septerna Inc: Qtrly Loss per Share $8.40

THOMSON REUTERS

Press Release: Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Septerna started by J.P. Morgan at overweight, GPCR platform cited

Septerna Initiated at Overweight by Wells Fargo

Cantor Fitzgerald Initiates Coverage on Septerna With Overweight Rating, $50 Price Target

MT Newswires Live

Septerna initiated with an Overweight at Cantor Fitzgerald

Buy Rating for Septerna, Inc. Driven by Innovative Drug Design and Promising SEP-786 Therapy

Septerna, Inc.: Strategic Innovation in GPCR Drug Development Drives Buy Rating

Septerna initiated with a Buy at TD Cowen

Septerna initiated with an Overweight at Wells Fargo

Innovative Biopharma Strategies and Promising Pipeline Position Septerna, Inc. for Mid-Term Outperformance

Septerna initiated with an Overweight at JPMorgan

Ra Capital Management Lp Reports 15.8% Stake in Septerna Inc as of October 28 - SEC Filing

THOMSON REUTERS

BRIEF-Septerna Announces Closing Of $331.2 Million Upsized Initial Public Offering

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering

THOMSON REUTERS

Press Release: Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SEPN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SEPN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SEPN\",,,,,undefined,":{"symbol":"SEPN","market":"US","secType":"STK","nameCN":"Septerna, Inc.","latestPrice":6.69,"timestamp":1746820800000,"preClose":6.95,"halted":0,"volume":164758,"hourTrading":{"tag":"盘后","latestPrice":6.69,"preClose":6.69,"latestTime":"16:05 EDT","volume":2059,"amount":13775.04,"timestamp":1746821106399},"delay":0,"floatShares":19629894,"shares":44442496,"eps":-7.26,"marketStatus":"Market Closed","change":-0.26,"latestTime":"05-09 16:00:00 EDT","open":6.96,"high":7.1591,"low":6.65,"amount":1114834.4052,"amplitude":0.073252,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.26,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"listingDate":1729828800000,"exchange":"NASDAQ","adjPreClose":6.95,"postHourTrading":{"tag":"盘后","latestPrice":6.69,"preClose":6.69,"latestTime":"16:05 EDT","volume":2059,"amount":13775.04,"timestamp":1746821106399},"volumeRatio":0.8576268086219464,"impliedVol":1.3499,"impliedVolPercentile":0.8361},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SEPN\",,,,,undefined,":{"symbol":"SEPN","floatShares":19629894,"roa":"-17.20%","roe":"-27.05%","lyrEps":-7.258829,"volumeRatio":0.8576268086219464,"shares":44442496,"dividePrice":0,"high":7.1591,"amplitude":0.073252,"preClose":6.95,"low":6.65,"week52Low":4.17,"pbRate":"0.71","psRate":"276.58","week52High":28.99,"institutionHeld":0,"latestPrice":6.69,"eps":-7.26,"divideRate":0,"volume":164758,"delay":0,"ttmEps":-7.26,"open":6.96,"prevYearClose":22.9,"prevWeekClose":7.48,"prevMonthClose":6.96,"prevQuarterClose":5.79,"fiveDayClose":7.48,"twentyDayClose":5.16,"sixtyDayClose":11.32},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SEPN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2485219101","title":"Septerna Shares Fall 7% After Wider 3Q Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2485219101","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485219101?lang=en_us&edition=fundamental","pubTime":"2024-11-21 03:14","pubTimestamp":1732130040,"startTime":"0","endTime":"0","summary":"Shares of Septerna fell after the company reported a wider loss in the third quarter following its initial public offering on October.The stock fell 7% to $22.43 on Wednesday. For the week, shares are down 3.4%.The San Francisco biotechnology company reported a loss of $20.5 million, or $8.40 a share, compared with a loss of $10.9 million, or $5.45 a share, in last year's third quarter.Revenue grew to $176 million from $33 million a year earlier. Research and development expenses rose to $17.8 million from $9.28 million, while general and administrative expenses also grew to $4.89 million from $2.79 million a year earlier.In October, the company completed its IPO with net proceeds of around $302.6 million. Septerna also appointed Jae Kim as chief medical officer in September to lead an expanded team and help the company's transition to a clinical-stage organization.Septerna's cash, cash equivalents and marketable securities were $137.5 million as of Sept. 30. The company expects its cu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2484136911","title":"Septerna's Q3 Loss Widens, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2484136911","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484136911?lang=en_us&edition=fundamental","pubTime":"2024-11-20 20:53","pubTimestamp":1732107181,"startTime":"0","endTime":"0","summary":"Septerna (SEPN) reported a Q3 loss Wednesday of $8.40, wider than a loss of $5.45 a year earlier.Three analysts polled by FactSet expected a loss of $7.41.Revenue for the quarter ended Sept. 30 was $176,000 compared with $33,000 a year earlier.Two analysts polled by FactSet expected $200,000.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SEPN"],"gpt_icon":0},{"id":"2484926197","title":"BRIEF-Septerna Reports Third Quarter 2024 Financial Results And Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2484926197","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484926197?lang=en_us&edition=fundamental","pubTime":"2024-11-20 20:15","pubTimestamp":1732104959,"startTime":"0","endTime":"0","summary":"BRIEF-Septerna Reports Third Quarter 2024 Financial Results And Recent Business HighlightsNov 20 (Reuters) - Septerna Inc SEPN.O:SEPTERNA REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND RECENT BUSINE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUA17HDR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2484192748","title":"Septerna Inc: Qtrly Loss per Share $8.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2484192748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484192748?lang=en_us&edition=fundamental","pubTime":"2024-11-20 20:00","pubTimestamp":1732104003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nTUA17HDR1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2484192773","title":"Press Release: Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2484192773","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484192773?lang=en_us&edition=fundamental","pubTime":"2024-11-20 20:00","pubTimestamp":1732104000,"startTime":"0","endTime":"0","summary":"Deep Pipeline of GPCR Programs Focused Initially on Indications in Endocrinology, Immunology and Inflammation, and Metabolic Diseases. Phase 1 Clinical Trial Ongoing for SEP-786, Oral Small Molecule for Hypoparathyroidism, with Data Expected in Mid-2025. Well-Capitalized with Balance Sheet to Support a Planned Operating Runway into Second Half of 2027. SOUTH SAN FRANCISCO, Calif., Nov. 20, 2024  -- Septerna, Inc. , a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor  drug discovery, today reported financial results for the third quarter ended September 30, 2024 and provided a portfolio overview and business highlights.Septerna's proprietary Native Complex Platform is uniquely designed to enable targeting of GPCRs with a wide spectrum of pharmacologies to affect GPCR signaling in different ways to achieve desired therapeutic effects. Using this platform, Septerna aims to discover and develop a portfolio of oral small molecule GPCR-targeted medicines","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","03160","BK4007","BK4555","BK4585","BK4181","GPCR","BK4588","PD","TSHR","TM","IPO","LU1169589451.USD","BK4023","SEPN","PK","LU1169590202.USD","BK4218"],"gpt_icon":0},{"id":"2484974096","title":"Septerna started by J.P. Morgan at overweight, GPCR platform cited","url":"https://stock-news.laohu8.com/highlight/detail?id=2484974096","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484974096?lang=en_us&edition=fundamental","pubTime":"2024-11-20 03:21","pubTimestamp":1732044098,"startTime":"0","endTime":"0","summary":"ismagilov/iStock via Getty Images  J.P. Morgan has initiated coverage of Septerna  with an overweight rating, citing the company’s platform for GPCR drug design. “Notwithstanding manifold newly actionable GPCR targets, we see Septerna  executing a highly attractive pipeline strategy, focused on validated targets in large established indications where an oral option offers a clear benefit to patients,” the bank said in a note.  The bank said it expects Septerna  shares to outperform its broader coverage midterm in view of a potential de-risking catalyst for its lead drug candidate in 2025, its cash runway to the second half of 2027, and business development prospects for non-core opportunities. J.P. Morgan set its price target for the stock at $38. Septerna  held its initial public offering in late October.","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1318624804/image_1318624804.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1318624804/image_1318624804.jpg?io=getty-c-w750"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4308597-septerna-started-by-jp-morgan-at-overweight-gpcr-platform-cited","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["SEPN","GPCR"],"gpt_icon":0},{"id":"2484947223","title":"Septerna Initiated at Overweight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2484947223","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484947223?lang=en_us&edition=fundamental","pubTime":"2024-11-19 22:14","pubTimestamp":1732025640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SEPN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 19, 2024 09:14 ET (14:14 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"ec7167944db3e98830b7f38d30a93ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN"],"gpt_icon":0},{"id":"2484944513","title":"Cantor Fitzgerald Initiates Coverage on Septerna With Overweight Rating, $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2484944513","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484944513?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:38","pubTimestamp":1732023502,"startTime":"0","endTime":"0","summary":"Septerna, Inc. (SEPN) has an average rating of Buy and mean price target of $43.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"ec7167944db3e98830b7f38d30a93ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SEPN"],"gpt_icon":0},{"id":"2484591743","title":"Septerna initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2484591743","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484591743?lang=en_us&edition=fundamental","pubTime":"2024-11-19 19:40","pubTimestamp":1732016449,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Josh Schimmer initiated coverage of Septerna (SEPN) with an Overweight rating and $50 price target Published first on The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-initiated-with-an-overweight-at-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":"ec7167944db3e98830b7f38d30a93ecc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-initiated-with-an-overweight-at-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"gpt_icon":0},{"id":"2484491439","title":"Buy Rating for Septerna, Inc. Driven by Innovative Drug Design and Promising SEP-786 Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2484491439","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484491439?lang=en_us&edition=fundamental","pubTime":"2024-11-19 18:57","pubTimestamp":1732013870,"startTime":"0","endTime":"0","summary":"Septerna, Inc. (SEPN) has received a new Buy rating, initiated by Wells Fargo analyst, Derek Archila. Derek Archila’s rating is based on a combinat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-for-septerna-inc-driven-by-innovative-drug-design-and-promising-sep-786-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-for-septerna-inc-driven-by-innovative-drug-design-and-promising-sep-786-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"gpt_icon":0},{"id":"2484919461","title":"Septerna, Inc.: Strategic Innovation in GPCR Drug Development Drives Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2484919461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484919461?lang=en_us&edition=fundamental","pubTime":"2024-11-19 18:46","pubTimestamp":1732013212,"startTime":"0","endTime":"0","summary":"Septerna, Inc. (SEPN) has received a new Buy rating, initiated by TD Cowen analyst, Yaron Werber. Yaron Werber has given his Buy rating due to a co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/septerna-inc-strategic-innovation-in-gpcr-drug-development-drives-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/septerna-inc-strategic-innovation-in-gpcr-drug-development-drives-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN","GPCR"],"gpt_icon":0},{"id":"2484919452","title":"Septerna initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2484919452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484919452?lang=en_us&edition=fundamental","pubTime":"2024-11-19 18:45","pubTimestamp":1732013126,"startTime":"0","endTime":"0","summary":"TD Cowen initiated coverage of Septerna (SEPN) with a Buy rating and no price target The company is applying its Native Complex platform to build a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-initiated-with-a-buy-at-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-initiated-with-a-buy-at-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN","BK4207","COWN","TD","BK4127","BK4566","BK4585"],"gpt_icon":0},{"id":"2484459919","title":"Septerna initiated with an Overweight at Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2484459919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484459919?lang=en_us&edition=fundamental","pubTime":"2024-11-19 18:45","pubTimestamp":1732013115,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Derek Archila initiated coverage of Septerna (SEPN) with an Overweight rating and $43 price target The firm believes there is u...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-initiated-with-an-overweight-at-wells-fargo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-initiated-with-an-overweight-at-wells-fargo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"gpt_icon":0},{"id":"2484919453","title":"Innovative Biopharma Strategies and Promising Pipeline Position Septerna, Inc. for Mid-Term Outperformance","url":"https://stock-news.laohu8.com/highlight/detail?id=2484919453","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484919453?lang=en_us&edition=fundamental","pubTime":"2024-11-19 18:35","pubTimestamp":1732012512,"startTime":"0","endTime":"0","summary":"Eric Joseph, an analyst from J.P. Morgan, has initiated a new Buy rating on Septerna, Inc. (SEPN). Eric Joseph has given his Buy rating due to a co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/innovative-biopharma-strategies-and-promising-pipeline-position-septerna-inc-for-mid-term-outperformance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/innovative-biopharma-strategies-and-promising-pipeline-position-septerna-inc-for-mid-term-outperformance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"gpt_icon":0},{"id":"2484891537","title":"Septerna initiated with an Overweight at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2484891537","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484891537?lang=en_us&edition=fundamental","pubTime":"2024-11-19 18:10","pubTimestamp":1732011019,"startTime":"0","endTime":"0","summary":"JPMorgan analyst Eric Joseph initiated coverage of Septerna (SEPN) with an Overweight rating and $38 price target Septerna represents a differentia...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-initiated-with-an-overweight-at-jpmorgan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-initiated-with-an-overweight-at-jpmorgan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"gpt_icon":0},{"id":"2481250550","title":"Ra Capital Management Lp Reports 15.8% Stake in Septerna Inc as of October 28 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2481250550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481250550?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:42","pubTimestamp":1730756565,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nFWN3MB125:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SEPN"],"gpt_icon":0},{"id":"2479767571","title":"BRIEF-Septerna Announces Closing Of $331.2 Million Upsized Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2479767571","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479767571?lang=en_us&edition=fundamental","pubTime":"2024-10-31 06:19","pubTimestamp":1730326750,"startTime":"0","endTime":"0","summary":"Oct 30 (Reuters) - Septerna Inc   :   * SEPTERNA ANNOUNCES CLOSING OF $331.2 MILLION UPSIZED INITIAL PUBLIC OFFERINGSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN"],"gpt_icon":0},{"id":"2479763189","title":"Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2479763189","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479763189?lang=en_us&edition=fundamental","pubTime":"2024-10-31 04:41","pubTimestamp":1730320918,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nTUA8WDNZ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SEPN"],"gpt_icon":0},{"id":"2479415763","title":"Press Release: Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2479415763","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479415763?lang=en_us&edition=fundamental","pubTime":"2024-10-31 04:41","pubTimestamp":1730320860,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Oct. 30, 2024  -- Septerna, Inc. , a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor  oral small molecule drug discovery, today announced the closing of its upsized initial public offering  of 18,400,000 shares of its common stock at a public offering price of $18.00 per share, which includes an additional 2,400,000 shares issued upon the full exercise by the underwriters of their option to purchase additional shares. All of the shares were offered by Septerna.The aggregate gross proceeds to Septerna from the IPO were $331.2 million, before deducting underwriting discounts and commissions and other offering expenses. The shares began trading on the Nasdaq Global Market on October 25, 2024, under the ticker symbol \"SEPN.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPO","TM","BK4099","BK4588","03160","GPCR","BK4007","BK4555","SEPN","BK4585","USA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SEPN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"SEPN","fiscalQuarterEnding":"2024/12","expectedEps":-0.69,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.64}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SEPN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SEPN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.75,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1739937600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SEPN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SEPN","date":"2025-05-09","current":-4.302005,"percent":0.689394,"low":-71.269737,"twenty":-59.827198,"median":-17.393535,"eighty":-3.586448,"high":261.261398,"avg":2.774449,"sd":92.981523,"marketCap":308875347},"quantilePoints":[{"date":"2024-10-25","current":180.873276,"twenty":180.873276,"median":180.873276,"eighty":180.873276,"marketCap":756050292},{"date":"2024-10-31","current":204.688257,"twenty":197.111676,"median":204.688257,"eighty":209.813,"marketCap":855596913},{"date":"2024-11-08","current":261.261398,"twenty":203.984861,"median":216.997688,"eighty":242.57116,"marketCap":1092072644},{"date":"2024-11-15","current":224.885772,"twenty":207.743006,"median":230.613426,"eighty":256.156752,"marketCap":940022529},{"date":"2024-11-22","current":-56.371082,"twenty":203.984861,"median":228.503238,"eighty":245.706296,"marketCap":915240881},{"date":"2024-11-29","current":-69.163916,"twenty":-57.105794,"median":221.92146,"eighty":240.581553,"marketCap":1122945345},{"date":"2024-12-06","current":-68.890433,"twenty":-66.926823,"median":208.506693,"eighty":237.707678,"marketCap":1118505070},{"date":"2024-12-13","current":-61.725172,"twenty":-67.501138,"median":191.022276,"eighty":236.763117,"marketCap":1002169886},{"date":"2024-12-20","current":-63.995083,"twenty":-66.784612,"median":-58.207863,"eighty":234.592638,"marketCap":1039024162},{"date":"2024-12-27","current":-70.449288,"twenty":-68.420042,"median":-60.166317,"eighty":232.180994,"marketCap":1143814633},{"date":"2025-01-03","current":-58.388676,"twenty":-68.655237,"median":-61.232902,"eighty":229.769351,"marketCap":947998541},{"date":"2025-01-10","current":-57.02126,"twenty":-67.714455,"median":-60.412452,"eighty":226.39305,"marketCap":925797170},{"date":"2025-01-17","current":-46.437457,"twenty":-67.358927,"median":-58.853597,"eighty":224.885772,"marketCap":753958559},{"date":"2025-01-24","current":-50.266223,"twenty":-66.593173,"median":-57.614562,"eighty":220.142874,"marketCap":816122397},{"date":"2025-01-31","current":-48.433885,"twenty":-66.401735,"median":-55.982023,"eighty":215.822012,"marketCap":786372560},{"date":"2025-02-07","current":-38.861971,"twenty":-65.110894,"median":-50.840537,"eighty":209.813,"marketCap":630962963},{"date":"2025-02-14","current":-31.587316,"twenty":-64.153703,"median":-49.199638,"eighty":205.451944,"marketCap":512851670},{"date":"2025-02-21","current":-16.108164,"twenty":-63.748948,"median":-46.492154,"eighty":202.578068,"marketCap":261532150},{"date":"2025-02-28","current":-15.862029,"twenty":-63.55204,"median":-46.410109,"eighty":188.992476,"marketCap":257535903},{"date":"2025-03-07","current":-17.393535,"twenty":-63.169163,"median":-46.191322,"eighty":63.291545,"marketCap":282401439},{"date":"2025-03-14","current":-17.47558,"twenty":-62.928498,"median":-43.237703,"eighty":-15.145503,"marketCap":283733521},{"date":"2025-03-21","current":-16.81922,"twenty":-62.747999,"median":-39.764466,"eighty":-15.424456,"marketCap":273076863},{"date":"2025-03-28","current":-3.893469,"twenty":-62.08617,"median":-37.439858,"eighty":-15.424456,"marketCap":279543299},{"date":"2025-04-04","current":-3.590162,"twenty":-61.462628,"median":-35.44343,"eighty":-3.701581,"marketCap":257766476},{"date":"2025-04-11","current":-3.194007,"twenty":-61.271189,"median":-31.04035,"eighty":-3.397655,"marketCap":229323279},{"date":"2025-04-17","current":-3.707771,"twenty":-61.249311,"median":-18.610536,"eighty":-3.429843,"marketCap":266210551},{"date":"2025-04-25","current":-3.998698,"twenty":-60.904722,"median":-17.913153,"eighty":-3.49979,"marketCap":287098524},{"date":"2025-05-02","current":-4.419614,"twenty":-60.313998,"median":-17.530277,"eighty":-3.557975,"marketCap":317319421},{"date":"2025-05-09","current":-4.302005,"twenty":-59.827198,"median":-17.393535,"eighty":-3.586448,"marketCap":308875347}],"updateTime":1746973577700}}}